Successful establishment and five-year sustainability of a neonatal-specific antimicrobial stewardship program in a low middle-income country

dc.contributor.authorMaalouf, Faouzi I.
dc.contributor.authorSaad, Thérèse
dc.contributor.authorZakhour, Ramia G.
dc.contributor.authorYunis, Khalid A.
dc.contributor.departmentPediatrics and Adolescent Medicine
dc.contributor.departmentPharmacology and Toxicology
dc.contributor.departmentDivision of Neonatology
dc.contributor.departmentPharmacy
dc.contributor.departmentDivision of Pediatric Infectious Diseases
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T12:11:26Z
dc.date.available2025-01-24T12:11:26Z
dc.date.issued2023
dc.description.abstractIntroduction: Antibiotic use varies substantially among neonatal intensive care units (NICUs) without any appreciable impact on outcomes. An increased use of antimicrobials has been reported in low-middle income countries. This raises the concern for potential overuse of antibiotics in a fragile patient population, thus increasing the rates of multidrug resistant organisms and affecting the developing microbiome. The presence of a neonatal-specific antimicrobial stewardship program can aid with the judicious use of antibiotics in the neonatal population and thus decrease the overuse of such medications. Methods: In this quality improvement project, we established and implemented a neonatal-specific antimicrobial stewardship program with the aim of reducing antimicrobial use in the neonatal intensive care units within a year of starting. Several interventions using a multidisciplinary approach included implementing standard algorithms, direct audit and feedback, and automated hard stops. Results: These series of interventions led to a 35% decrease in antimicrobial usage in the first 3 months and further decrease was seen with a median of 63% decline for a total of 5 years after project implementation. The use of the most commonly prescribed antibiotics, ampicillin and gentamicin, decreased by 63% and 79%, respectively. There was no evidence that this change in practice affected or jeopardized patient outcomes. Additionally, it showed sustainability and resilience despite the many challenges such as COVID-19 pandemic, political and financial unrest, and healthcare sector collapse. Discussion: This model-based and multidisciplinary low-cost approach can lead to marked improvement affecting neonatal outcomes and can be replicated in other similar centers. Copyright © 2023 Maalouf, Saad, Zakhour and Yunis.
dc.identifier.doihttps://doi.org/10.3389/fphar.2022.1076392
dc.identifier.eid2-s2.0-85146443763
dc.identifier.urihttp://hdl.handle.net/10938/32561
dc.language.isoen
dc.publisherFrontiers Media S.A.
dc.relation.ispartofFrontiers in Pharmacology
dc.sourceScopus
dc.subjectAntibiotic usage rate
dc.subjectAntimicrobial stewardship
dc.subjectNeonates
dc.subjectPrematurity
dc.subjectQuality improvement
dc.subjectAmpicillin
dc.subjectGentamicin
dc.subjectAlgorithm
dc.subjectArticle
dc.subjectClinical audit
dc.subjectClinical outcome
dc.subjectClinical practice
dc.subjectControlled study
dc.subjectCoronavirus disease 2019
dc.subjectDrug overdose
dc.subjectDrug use
dc.subjectFemale
dc.subjectHuman
dc.subjectMajor clinical study
dc.subjectMale
dc.subjectMiddle income country
dc.subjectMultidisciplinary team
dc.subjectNeonatal intensive care unit
dc.subjectNewborn
dc.subjectOutcome assessment
dc.subjectPandemic
dc.subjectPediatric patient
dc.subjectPrescription
dc.subjectProgram sustainability
dc.subjectRetrospective study
dc.subjectTotal quality management
dc.titleSuccessful establishment and five-year sustainability of a neonatal-specific antimicrobial stewardship program in a low middle-income country
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2023-975.pdf
Size:
1.29 MB
Format:
Adobe Portable Document Format